Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
Plos One|May 24, 2011
Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosisRichard A Rudick, M R Sandhya Rani, Yaomin Xu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsE Fisher, R A Rudick, G Cutter, et al.
Archives of Neurology|July 14, 2010
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-upRichard A Rudick, Jar-Chi Lee, Gary R Cutter, et al.
Journal of Visualized Experiments : Jove|July 22, 2014
The Multiple Sclerosis Performance Test (MSPT): an iPad-based disability assessment toolRichard A Rudick, Deborah Miller, Francois Bethoux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2018
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosisLauren Strober, John DeLuca, Ralph Hb Benedict, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosisDeborah M Miller, Richard A Rudick, Monika Baier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening QuestionnaireR H B Benedict, J A Duquin, S Jurgensen, et al.
European Journal of Neurology|June 17, 2005
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosisM Zorzon, R Zivadinov, L Locatelli, et al.
The Online Journal of Current Clinical Trials|September 25, 1992
Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicityD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.
AJR. American Journal of Roentgenology|July 1, 1989
High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis?A S Smith, D M Meisler, M A Weinstein, et al.
Pageof 19